Impulse Dynamics Completes $158M Financing Round

by Impulse Dynamics | Dec 10, 2025 | Press Releases

Investment to Fuel Strategic Growth and Future Product Commercialization MARLTON, N.J., DEC 10th, 2025 (GLOBE NEWSWIRE) — Impulse Dynamics®, a global medical device company committed to improving the lives of people with heart failure (HF), announced today that it...

Impulse Dynamics Celebrates CMS National Coverage Determination for CCM Therapy

by Impulse Dynamics | Oct 29, 2025 | Press Releases

Decision Immediately Expands Access to Heart Failure Therapywith National Coverage for More Than 66 Million(1) Patients MARLTON, N.J., OCT 29th, 2025 (GLOBE NEWSWIRE) — Impulse Dynamics®, a global medical device company committed to improving the lives of people with...

Impulse Dynamics® Completes Enrollment of Pivotal Trial for CCM-D® HF System and Earns Category 1 CPT Codes for CCM® Therapy

by Impulse Dynamics | Jul 28, 2025 | Press Releases

Paving the Way for Broader Access and the First Combined CCM®/ICD System MARLTON, N.J., July 28, 2025 (GLOBE NEWSWIRE) — Impulse Dynamics®, a global medical device company committed to improving the lives of people with heart failure (HF), announced two major...

Impulse Dynamics®’ INTEGRA-D Trial Completes Efficacy Phase

by Impulse Dynamics | Apr 28, 2025 | Press Releases

First phase of enrollment of single device for CCM® and ICD therapy complete MARLTON, N.J., April 28, 2025 (GLOBE NEWSWIRE) — Impulse Dynamics® plc, a global medical device company dedicated to improving the lives of people with heart failure (HF), is proud to...

Impulse Dynamics Receives European CE Mark For Expanded Indication For Diastolic Heart Failure

by Impulse Dynamics | Mar 28, 2025 | Press Releases

CCM therapy is now indicated for symptomatic heart failure patients with diastolic or systolic ventricular dysfunction, offering a broader range of patients a new option for improving quality of life and reducing heart failure hospitalization MARLTON, N.J., March 28,...